库拉肿瘤 KURA
$7.27 +$0.47 (+6.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.27 0.00%
开盘$6.91
昨收$6.80
当日区间$6.75 – $7.40
成交量3.09M
市值$646.74M
市盈率（TTM）–
股息率–
KURA 相关新闻
匹配 Kura Oncology 或代码 KURA 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40
- BofA Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $31
- Kura Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Powl Brian T.
- SBI Securities Keeps Their Buy Rating on Kura Sushi, Inc. (2695)
- William Blair Maintains Kura Sushi USA(KRUS.US) With Buy Rating
- Kura Sushi, Inc. (2695) Receives a Hold From Mizuho Securities
- Barclays Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28
- Lake Street Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $23
- Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25
- UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $15
- A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $23 to $40
- A Quick Look at Today's Ratings for Kura Oncology(KURA.US), With a Forecast Between $28 to $40
- Craig-Hallum Maintains Kura Sushi USA(KRUS.US) With Buy Rating, Announces Target Price $80
- Speee: Secret remittance demo "Kura Pay" and the beta version of "KuraPrivacy Service API" are now available.
- Wedbush Maintains Kura Oncology(KURA.US) With Buy Rating, Raises Target Price to $36 正面
暂无评论——快来第一个聊聊 KURA。
登录后参与讨论。